LeMaitre Vascular director exercises rights for shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
LeMaitre Vascular director Lawrence J. Jasinski reported the release and exercise of dividend equivalent rights on 2025-12-12, converting those rights into 10 shares of common stock at $0.0000 per share in connection with vesting of 2022 restricted and performance stock unit awards. Fractional share amounts, if any, were settled in cash, leaving no remaining dividend equivalent rights. Following these transactions, he directly holds 5,322 shares of common stock.
Insider Trade Summary
10 shares exercised/converted
Exercise
4 txns
Insider
Jasinski Lawrence J
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Dividend Equivalent Rights | 5 | $0.00 | $0.00 |
| Exercise | Dividend Equivalent Rights | 5 | $0.00 | $0.00 |
| Exercise | Common Stock | 5 | $0.00 | $0.00 |
| Exercise | Common Stock | 5 | $0.00 | $0.00 |
Holdings After Transaction:
Dividend Equivalent Rights — 0 contracts (Direct);
Common Stock — 5,322 shares (Direct)
Footnotes (4)
- F1. Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
- F2. These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
- F3. Fractional shares (if any) were settled in cash on each vesting date, resulting in a final balance of zero.
- F4. These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
Key Figures
Shares from rights exercised: 10 shares
Post-transaction holdings: 5,322 shares
Exercise price: $0.0000 per share
+1 more
4 metrics
Shares from rights exercised
10 shares
Dividend equivalent rights released and converted on 2025-12-12
Post-transaction holdings
5,322 shares
Director’s direct common stock position after reported transactions
Exercise price
$0.0000 per share
Dividend equivalent rights converted into common stock at no cash cost
Award grant date
12/12/2022
Restricted and performance stock unit awards linked to the rights
Key Terms
Dividend Equivalent Rights, restricted stock unit award, performance stock unit award, fractional shares
4 terms
Dividend Equivalent Rights financial
"Represents shares acquired upon release of dividend equivalent rights, as reported in Table II"
Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.
restricted stock unit award financial
"released in connection with the vesting of a restricted stock unit award granted on 12/12/2022"
A restricted stock unit award is a promise by a company to give an employee a specified number of company shares at a future date if certain conditions are met, such as staying with the company or hitting performance goals. For investors, these awards matter because they can increase the total number of shares outstanding when converted, diluting existing holders, and they align employees’ incentives with shareholders’ interests much like giving a rising bonus that becomes real only after conditions are satisfied.
performance stock unit award financial
"released in connection with the vesting of a performance stock unit award granted on 12/12/2022"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did LMAT director Lawrence Jasinski report in this Form 4?
Lawrence Jasinski reported the release and exercise of dividend equivalent rights, converting them into 10 shares of LeMaitre Vascular common stock on 2025-12-12. These were tied to vesting of 2022 restricted and performance stock unit awards, with fractional shares settled in cash.
What are dividend equivalent rights mentioned in LMAT’s Form 4?
Dividend equivalent rights in this filing are instruments economically equivalent to one share of LMAT common stock each. They were released when 2022 restricted and performance stock unit awards vested, and then converted into common shares, with any fractional amounts settled in cash.
Were the LMAT dividend equivalent rights linked to specific grant dates?
Yes. The dividend equivalent rights were released upon vesting of restricted and performance stock unit awards granted on 12/12/2022. When those awards vested on 2025-12-12, the related rights converted into LMAT common shares on a one-for-one basis.
AI-generated analysis. How Rhea-AI works. Not financial advice.
